Intensified Mission Indradhanush 5.0 concludes, 5.06 crore children vaccinated since 2014 says govt

The Intensified Mission Indradhanush (IMI 5.0) campaign, spearheaded by the Union Ministry of Health and Family Welfare, concluded its three rounds on 14th October 2023, targeting missed-out children and pregnant women nationwide.

Published On 2023-10-14 04:45 GMT   |   Update On 2024-02-14 06:06 GMT

New Delhi: Intensified Mission Indradhanush (IMI 5.0), the flagship routine immunization campaign of the Union Ministry of Health and Family Welfare concluded all 3 rounds on 14th October 2023, the central government recently informed . IMI 5.0 was targeted to ensure that routine immunization services reach the missed-out and dropped out children and pregnant women across the country.This...

Login or Register to read the full article

New Delhi: Intensified Mission Indradhanush (IMI 5.0), the flagship routine immunization campaign of the Union Ministry of Health and Family Welfare concluded all 3 rounds on 14th October 2023, the central government recently informed . IMI 5.0 was targeted to ensure that routine immunization services reach the missed-out and dropped out children and pregnant women across the country.

This year, for the first time the campaign was conducted across all the districts in the country and includes children up to 5 years of age (Previous campaigns included children up to 2 years of age).

Also Read:Immunization : Dr. Mansukh Mandaviya launched Intensified Mission Indradhanush (IMI) 4.0 virtually

IMI 5.0 campaign aimed to enhance immunization coverage for all vaccines provided under the Universal Immunization Programme (UIP) as per the National Immunization Schedule (NIS).

Special focus was laid on improvement of Measles and Rubella vaccination coverage with the aim of Measles & Rubella elimination by 2023 and use of U-WIN digital platform for Routine Immunization in pilot mode across all districts in the country.

IMI 5.0 has been conducted in three rounds i.e., 7 -12 August, 11-16 September, and 9-14 October 2023 i.e., 6 days in a month with the inclusion of a Routine Immunization Day. All States/UTs except Bihar, Chhattisgarh, Odisha and Punjab would conclude all the three rounds of IMI 5.0 campaign by 14th October 2023.

These four states could not start the IMI 5.0 campaign in August due to some inevitable circumstances. These states have concluded 1st round and are currently conducting the 2nd round. They plan to conduct the 3rd round of IMI 5.0 campaign in the month of November 2023.

As on 30th September 2023, over 34,69,705 children and 6,55,480 pregnant women were administered vaccine doses during the first 2 rounds of IMI 5.0 campaign across the country.

Preparedness Assessment for IMI 5.0 was conducted by National Monitors between 19th July and 23rd July 2023. They carried out extensive preparedness assessments across 154 High-priority districts in 27 States/UTs. The findings of the preparedness assessment along with the recommendations were shared all the States/UTs.

A National Workshop on IMI 5.0 was conducted by on 23rd June 2023 at National Capital to orient all States/UTs about the campaign.

Operational Guidelines along with Communication Strategy was shared with all States/ UTs. The communication strategy included 360 -degree communication approach with strategies to include advocacy, addressing vaccine hesitancy and engaging local influencers and leaders. Various IEC materials were shared with all States/UTs for adaptation in local languages and effectively reach out to masses with key messages.

IMI 5.0 saw participation from Jan pratinidhis and Social Media Influencers have come forward in large numbers across all States/UTs to appeal to public to visit nearest vaccination centres and take any missed doses for children and pregnant women in the family and community.

Since 2014, 11 phases of Mission Indradhanush have been completed across the country. 12th phase is currently ongoing, a total of 5.06 crore children and 1.25 crore pregnant women have been cumulatively vaccinated till date under the campaign.

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News